Create issue ticket

1,680 Possible Causes for Platinum, cis

Show results in: Română

  • Influenza

    Products for Influenza Research Include: PureLink Viral RNA/DNA Mini Kit SuperScript III Platinum One-Step qRT-PCR Kit Research Tools for Detection Step 2.[thermofisher.com] CI -2.93 to 0.01); NNTH 150 (NNTH 35 to NNTB 1000) and nausea whilst on treatment (RD 4.15%, 95% CI 0.86 to 9.51); NNTH 25 (95% CI 11 to 116).[ncbi.nlm.nih.gov] The qRT-PCR assays were performed on the MX3005P (Agilent Technologies) using the SuperScript III Platinum One-step Quantitative RT-PCR system (Invitrogen).[doi.org]

  • Osteoporosis

    Platinum To achieve the platinum level of evidence, a published systematic review that has at least two randomized controlled trials, each satisfying the following, is required[doi.org] CI) 0.56 [0.35, 0.92] 2 No.[doi.org] Platinum: To achieve the platinum level of evidence, a published systematic review that has at least two randomized controlled trials each satisfying the following is required[doi.org]

  • Relapsed Small Cell Lung Cancer

    Six-month OS rate: 37% (95% CI: 28-46%). One-year OS rate: 9% (95% CI: 5-13%). Response rate: 5% (95% CI: 1-8%). Six-month OS rate: 57% (95% CI: 50-64%).[ncbi.nlm.nih.gov] We evaluated the outcome of rechallenge with platinum-based chemotherapy for sensitive relapse patients.[ncbi.nlm.nih.gov] The median OS times were: overall 9.6 months (95% CI: 7.2-12.5 months); sensitive cases 8.4 months (95% CI: 4.6-13.4 months); and refractory cases 11.0 months (95% CI: 6.5[ncbi.nlm.nih.gov]

  • Carboplatin

    Cis-RT).[ncbi.nlm.nih.gov] KEYWORDS: PET; fluorinated carboplatin; platinum; theranostics [Indexed for MEDLINE] Free full text[ncbi.nlm.nih.gov] Carboplatin and other platinum-based drugs chemically bond with thiol sulfurs and amino groups in the cells' nucleic acids.[carboplatin.org]

  • Sunburn

    CASE REPORT: A patient with platinum-resistant ovarian cancer, responded to, and tolerated (including no skin rash) an initial cycle of liposomal doxorubicin (40 mg/m(2)).[ncbi.nlm.nih.gov] […] vs 7.7%; aPOR 1.55; 95% CI 1.21-1.98), a wide-brimmed hat (26.1% vs 10.5%; aPOR 1.52; 95% CI 1.24-1.87), and sunscreen (53.7% vs 33.1%; aPOR 2.11; 95% CI 1.73-2.59), but[ncbi.nlm.nih.gov] Here is how the Fitzpatrick Scale works: Type 1 skin always burns and never tans, which is typical of redheads and platinum blondes.[livescience.com]

  • Cisplatin

    cis-Diamminedichloroplatinum(II), Pt 64.5% min MDL MFCD00011623 EINECS 239-733-8 Chemical Properties Formula Cl 2 H 6 N 2 Pt Formula Weight 300.06 Form Micro Crystals Melting[alfa.com] Here, we present data indicating that EZH2 overexpression is associated with cisplatin resistance and intracellular platinum drug accumulation.[ncbi.nlm.nih.gov] How can I get Product 479306,cis-Diammineplatinum(II) dichloride, in solution? cis-Diammineplatinum(II) dichloride is soluble in water at 25 C.[sigmaaldrich.com]

  • Malignant Neoplasm

    The mortality ratios of stomach cancer (56%, 95% CI: 41%-72%) and liver cancer (52%, 95% CI: 32%-80%) were significantly decreased.[ncbi.nlm.nih.gov] Device: ultrasonic microbubbles inject 1ml once and five times in 20min, locate the probe on the lesion at the same time Other Name: Sonovue Drug: platinum and gemcitabine[clinicaltrials.gov] In this study, 1,160 patients were enrolled and treated with platinum-based chemotherapy plus bevacizumab for up to four cycles.[doi.org]

  • Squamous Cell Carcinoma of the Head and Neck

    […] older with histologically or cytologically confirmed recurrent and metastatic squamous cell carcinoma of the head and neck after disease progression on or after one previous platinum-based[ncbi.nlm.nih.gov] One-, 3-, and 5-year overall survival were 81% (CI 67%-89%), 59% (CI 41%-73%), and 42% (CI 22%-61%), respectively.[ncbi.nlm.nih.gov] […] chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.[news.bms.com]

  • Epithelial Ovarian Cancer

    ]), any grade 3 or 4 adverse event (RR: 0.29 [95% CI: 0.11 to 0.78]), and less post-surgical death within 28 days (RR: 0.14 [95% CI: 0.04 to 0.49]).[ncbi.nlm.nih.gov] […] of treating platinum- and paclitaxel-resistant ovarian cancer.[ncbi.nlm.nih.gov] […] by PET/CT (aOR, 3.59; 95% CI, 1.0-12.8).[ncbi.nlm.nih.gov]

  • Tuberculosis

    In blood and extrasanguinous fluids, the pooled specificity was 79% (95% CI 75-82%) and 82% (95% CI 70-91%) for QFT-G-IT, and 59% (95% CI 56-62%) and 82% (95% CI 78-86%) for[ncbi.nlm.nih.gov] […] dithiothreitol stabilizers (Sigma-Aldrich), 50% (v/v) glycerol, 1.5 m M of MgCl 2 , 40 p M of each primer, 0.2 m M each of nuclear triphosphates (MBI, Fermentas), and 1.25 U of Platinum[doi.org] CI 42%-64%) and comparable pooled specificity (98%, 95% CI 94%-99%).[ncbi.nlm.nih.gov]

Further symptoms